# Trade Mark Journal No.2026/021 22 May 2026

## WO0000001915938 (5,16,35,41,42,44)

Office of origin: United States of America

Date of International Registration:2 March 2026
Date of designation in the UK: 2 March 2026

The mark consists of a spark design with four short rays and two long rays emitting from the center.

International priority date claimed: 15 September 2025 (United States of America) (99393404)

Class 5
  Pharmaceutical preparations for the treatment and prevention of neurologic, rare neurologic, neuropsychiatric, rare neuropsychiatric, metabolic, rare metabolic, genetic, rare genetic, psychologic, rare psychologic, psychiatric, and rare psychiatric diseases and disorders.
Class 16
  Printed publications, namely, brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support.
Class 35
  Promoting awareness of patient support offerings for neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; promoting awareness of patient support offerings for pain associated with neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; business administration services in the field of healthcare, namely, business administration of reimbursement and medical benefit information for neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions and their treatment; business administration services in the field of healthcare, namely, business administration of reimbursement and medical benefit information for treatment of pain associated with neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions; business administrative services for medical referrals.
Class 41
  Educational services, namely, conducting programs in the field of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders and treatment and patient support options for these conditions.
Class 42
  Providing on-line non-downloadable software for administering medical benefits and enrolling in benefits patient support program services; biomedical research services; industrial research in the field of biotechnology; scientific research; scientific and technological services, namely, research and design in the field of biotechnology and biomedicine; providing scientific research information in the field of biotechnology and biomedicine; chemical, biochemical, biological and bacteriological research and analysis; biological research and analysis; testing of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; pharmaceutical research in the field of medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; providing medical research information in the field of pharmaceuticals.
Class 44
  Consultancy in the field of the medical treatment of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions; consultancy in the field of the medical diagnosis of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions; medical information; providing medical information via a website; providing personalized healthcare and medical information in the nature of providing information about the therapeutic benefits of pharmaceutical products, medical information regarding disease management, and healthcare-related information to patients and healthcare professionals in the fields of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; providing medical information in the field of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders.

Acadia Pharmaceuticals Inc.

Representative: Carissa L. Weiss Law Office of Carissa L. Weiss, PLLC, 745 Fifth Avenue, Suite 500, New York NY 10151, UNITED STATES OF AMERICA